Clovis Oncology Said to Explore Sale of Biotech Company

Clovis Oncology Inc., a developer of cancer treatments whose value has more than tripled this year, is exploring strategic options including a sale of the company, people with knowledge of the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.